Literature DB >> 16546097

Loss of Pax5 promotes plasma cell differentiation.

Kalle-Pekka Nera1, Pekka Kohonen, Elli Narvi, Anne Peippo, Laura Mustonen, Perttu Terho, Kimmo Koskela, Jean-Marie Buerstedde, Olli Lassila.   

Abstract

Pax5 is indispensable for the commitment of early lymphoid progenitors to the B cell lineage as well as for the development of B cells. To better understand the functional importance of Pax5 at the later stages of B cell differentiation, we established a Pax5-deficient DT40 B cell line. The Pax5(-/-) cells exhibited slower growth, decreased surface IgM expression, and total loss of B cell receptor signaling. Moreover, the expression of the plasma cell-characteristic transcription factors Blimp-1 and XBP-1 were significantly upregulated and the expression of Bcl-6 diminished in the Pax5(-/-) cells, and this alteration was normalized by restored Pax5 expression. The Pax5-deficient cells further manifested substantially elevated secretion of IgM into the supernatant, another characteristic of plasma cells. These results indicate that downregulation of Pax5 function promotes the plasma cell differentiation of B cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546097     DOI: 10.1016/j.immuni.2006.02.003

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  71 in total

Review 1.  Affinity of antigen encounter and other early B-cell signals determine B-cell fate.

Authors:  Micah J Benson; Loren D Erickson; Michael W Gleeson; Randolph J Noelle
Journal:  Curr Opin Immunol       Date:  2007-04-12       Impact factor: 7.486

2.  Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression.

Authors:  Heike Schmidlin; Sean A Diehl; Maho Nagasawa; Ferenc A Scheeren; Remko Schotte; Christel H Uittenbogaart; Hergen Spits; Bianca Blom
Journal:  Blood       Date:  2008-06-13       Impact factor: 22.113

Review 3.  The generation of antibody-secreting plasma cells.

Authors:  Stephen L Nutt; Philip D Hodgkin; David M Tarlinton; Lynn M Corcoran
Journal:  Nat Rev Immunol       Date:  2015-02-20       Impact factor: 53.106

Review 4.  Germinal centres and B cell lymphomagenesis.

Authors:  Katia Basso; Riccardo Dalla-Favera
Journal:  Nat Rev Immunol       Date:  2015-03       Impact factor: 53.106

5.  Expression pattern of XBP1(S) in human B-cell lymphomas.

Authors:  Lorena Maestre; Reuben Tooze; Marta Cañamero; Santiago Montes-Moreno; Rocio Ramos; Gina Doody; May Boll; Sharon Barrans; Sara Baena; Miguel Angel Piris; Giovanna Roncador
Journal:  Haematologica       Date:  2009-01-27       Impact factor: 9.941

6.  B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.

Authors:  Diana Cozma; Duonan Yu; Suchita Hodawadekar; Anna Azvolinsky; Shannon Grande; John W Tobias; Michele H Metzgar; Jennifer Paterson; Jan Erikson; Teresa Marafioti; John G Monroe; Michael L Atchison; Andrei Thomas-Tikhonenko
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 7.  Augmentation of antibody responses by retinoic acid and costimulatory molecules.

Authors:  A Catharine Ross; Qiuyan Chen; Yifan Ma
Journal:  Semin Immunol       Date:  2008-09-25       Impact factor: 11.130

Review 8.  New insights into the regulation of human B-cell differentiation.

Authors:  Heike Schmidlin; Sean A Diehl; Bianca Blom
Journal:  Trends Immunol       Date:  2009-05-15       Impact factor: 16.687

9.  The forkhead transcription factor FOXP1 represses human plasma cell differentiation.

Authors:  Martine van Keimpema; Leonie J Grüneberg; Michal Mokry; Ruben van Boxtel; Menno C van Zelm; Paul Coffer; Steven T Pals; Marcel Spaargaren
Journal:  Blood       Date:  2015-08-19       Impact factor: 22.113

10.  Olf1/EBF associated zinc finger protein interfered with antinuclear antibody production in patients with systemic lupus erythematosus.

Authors:  Xuebing Feng; Rongliang Li; Jing Huang; Huayong Zhang; Lina Zhu; Bingzhu Hua; Betty P Tsao; Lingyun Sun
Journal:  Arthritis Res Ther       Date:  2010-04-01       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.